Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1942 (LINC01942) is a type of long intergenic non-coding RNA (lincRNA), which refers to autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap with protein-coding genes[1][3]. LincRNAs are increasingly recognized for their roles in regulating gene expression by remodeling chromatin, scaffolding protein complexes, modulating transcription and RNA stability, and acting as enhancer-like elements[1][5]. While lincRNAs as a class are implicated in cancer, immune response, and development, LINC01942 itself has limited specific literature regarding function, disease association, or utility as a therapeutic target or biomarker as of current data. No drugs or direct drug mechanisms are reported for this gene, and it is not recognized as a classical therapeutic target[3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1942 (LINC01942).